NYSE:CDAY - Ceridian HCM Stock Price, Forecast & News

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CDAY shares have decreased by 14.1% and is now trading at $48.65. View which stocks have been mosted impacted by Coronavirus.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Ceridian HCM.

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for Ceridian HCM.

Ceridian HCM Holding Inc (NYSE:CDAY) issued its earnings results on Wednesday, February, 5th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.07 by $0.01. The company earned $221.80 million during the quarter, compared to analysts' expectations of $221.15 million. Ceridian HCM had a return on equity of 1.73% and a net margin of 9.55%. The firm's revenue for the quarter was up 10.7% on a year-over-year basis. During the same period last year, the business posted $0.07 earnings per share. View Ceridian HCM's earnings history.

Ceridian HCM issued an update on its FY 2020 After-Hours earnings guidance on Wednesday, February, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $903-908 million, compared to the consensus revenue estimate of $929.78 million.

16 Wall Street analysts have issued 1 year price targets for Ceridian HCM's shares. Their forecasts range from $51.00 to $87.00. On average, they anticipate Ceridian HCM's stock price to reach $69.50 in the next twelve months. This suggests a possible upside of 42.9% from the stock's current price. View analysts' price targets for Ceridian HCM.

Media coverage about CDAY stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ceridian HCM earned a news sentiment score of 0.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. View the latest news aboutCeridian HCM.

Ceridian HCM saw a increase in short interest in February. As of February 28th, there was short interest totaling 9,570,000 shares, an increase of 18.0% from the February 13th total of 8,110,000 shares. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is presently 8.1 days. Currently, 8.3% of the company's stock are sold short. View Ceridian HCM's Current Options Chain.

Some companies that are related to Ceridian HCM include Electronic Arts (EA), Square (SQ), Veeva Systems (VEEV), Splunk (SPLK), ANSYS (ANSS), Synopsys (SNPS), Cadence Design Systems (CDNS), Atlassian (TEAM), Citrix Systems (CTXS), Okta (OKTA), Docusign (DOCU), Tableau Software (DATA), Check Point Software Technologies (CHKP), Twilio (TWLO) and Paycom Software (PAYC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alibaba Group (BABA), NVIDIA (NVDA), Tesla (TSLA), Adobe (ADBE), Costco Wholesale (COST), Advanced Micro Devices (AMD), Wynn Resorts (WYNN), Alteryx (AYX) and UnitedHealth Group (UNH).

(CDAY) raised $420 million in an IPO on Thursday, April 26th 2018. The company issued 21,000,000 shares at $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Thomas H Lee Partners LP (12.97%), Capital Research Global Investors (8.64%), Artisan Partners Limited Partnership (5.25%), Bamco Inc. NY (1.94%), FMR LLC (1.66%) and Dragoneer Investment Group LLC (1.48%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View institutional ownership trends for Ceridian HCM.

CDAY stock was sold by a variety of institutional investors in the last quarter, including Thomas H Lee Partners LP, FMR LLC, Dragoneer Investment Group LLC, Bain Capital Public Equity Management II LLC, Partners Group Holding AG, Goldman Sachs Group Inc., Connor Clark & Lunn Investment Management Ltd., and Connor Clark & Lunn Investment Management Ltd.. Company insiders that have sold Ceridian HCM company stock in the last year include Arthur Gitajn, Cannae Holdings, Inc, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Scott A Kitching, and Thomas H Lee Advisors, Llc. View insider buying and selling activity for Ceridian HCM.

CDAY stock was acquired by a variety of institutional investors in the last quarter, including Capital Research Global Investors, State Street Corp, Artisan Partners Limited Partnership, Bank of New York Mellon Corp, Norges Bank, Principal Financial Group Inc., American International Group Inc., and Charles Schwab Investment Management Inc.. View insider buying and selling activity for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $48.65.

Ceridian HCM has a market capitalization of $6.94 billion and generates $824.10 million in revenue each year. The company earns $78.70 million in net income (profit) each year or $0.26 on an earnings per share basis. Ceridian HCM employs 5,011 workers across the globe. View additional information about Ceridian HCM.

The official website for Ceridian HCM is http://www.ceridian.com/.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]